Potential Candidacy for Liver Transplantation among Chronic Liver Disease Patients Presenting to Khyber Teaching Hospital, Peshawar
Keywords:
liver transplant, ; chronic liver disease, MELD-Na scoreAbstract
OBJECTIVE: To determine the frequency of potential candidates for liver transplantation among decompensated chronic liver parenchymal disease patients.
METHODOLOGY: This cross-sectional descriptive study was conducted in the Department of Medicine at Khyber Teaching Hospital, Peshawar, from September 2021 to February 2022. The study included 200 patients with decompensated chronic liver parenchymal disease. Their eligibility for liver transplantation was determined by calculating the MELD-Na score for each of them. Eligibility for liver transplant was correlated with a higher MELD-Na score (>25). Data were collected and entered in SPSS 25.
RESULTS: 168 of the 200 patients comprised those with viral hepatitis B or C (84%); 73.21% of these were hepatitis C positive, and 26.8% were hepatitis B positive; this was followed by patients with hepatocellular carcinoma (8%). 62.5% (5% of the total sample size) were HBV positive, and 37.5% (3% of the entire sample size) were HCV positive; however, HCC secondary to viral hepatitis was taken as an independent indication for a liver transplant. 4% of the patients had autoimmune hepatitis, 2% had NAFLD, and 2% were attributed to other causes. Of the 200 patients, 5% had MELD-Na score <9; 19% had MELD-Na score 10-19; 36% had MELD-Na score 20-29; 39% had MELD-Na score 30-39; 1% had MELD-Na score >40.
CONCLUSION: Many patients with DCLPD are potential candidates for liver transplantation. Hence, measures are needed to establish a liver transplant centre in Khyber Pakhtunkhwa.
References
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, KosbergCL et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70. doi: 10.1053/jhep.2001.22172.
Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health-related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes. 2012; 5: 446. doi: 10.1186/1756-0500 -5-446.
Bodzin AS, Baker TB. Liver Transplantation Today: Where We Are Now and Where We Are Going. Liver Transpl. 2018 Oct; 24(10): 1470-5. doi: 10.1002/lt.25320.
Al Kanaani Z, Mahmud S, Kouyoumjian SP, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Pakistan: Systematic Review and Meta-analyses. R Soc Open Sci. 2018; 5(4): 180257. doi: 10.1098/rsos.180257.
Bhatti ABH, Dar FS, Waheed A, Shafique K, Sultan F, Shah NH. Hepatocellular carcinoma in Pakistan: National Trends and Global Perspective. Gastroenterol Res Pract. 2016; 2016: 5942306. doi: 10.1155/2016/5942306. Epub 2016 Feb 3.
Global Burden Of Disease Cancer Collaboration; Fitzmaurice C, Abate D, Abbasi N, Abbastaber H, Abd-Allah F et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019 Dec 1; 5(12): 1749-1768. doi: 10.1001/jamaoncol.2019. 2996.
Bittermann T, Hubbard RA, Lewis JD, Goldberg DS. The proportion of the Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications. Clin Transplant. 2020 Mar; 34(3): e13817. doi: 10.1111/ctr.13817. Epub 2020 Feb 20.
Tschuor C, Ferrarese A, Kuemmerli C, Dutkowski P, Burra P, Clavien PA; Liver Allocation Study Group. Allocation of liver grafts worldwide - Is there a best system? J Hepatol. 2019 Oct; 71(4): 707-18. doi: 10.1016/j.jhep.2019.05.025. Epub 2019 Jun 12.
Ruf A, Dirchwolf M, Freeman RB. From Child-Pugh to MELD score and beyond Walking down memory lane. Ann Hepatol. 2022 Jan-Feb; 27(1): 100535. doi: 10.1016/j.aohep.2021. 100535. Epub 2021 Sep 22.
Goudsmit BFJ. Validation of the Model for End-stage Liver Disease Sodium (MELD-Na) Score in the Eurotransplant Region. Am J Transplant. 2021 Jan; 21(1): 229-40. doi: 10.1111/ajt.16142. Epub 2020 Aug 4.
Chinese Group on the Study of Severe Hepatitis B (COSSH). Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol. 2021 Nov; 75(5): 1104-1115. doi: 10.1016/j. jhep.2021.05.026. Epub 2021 Jun 4.
Acharya G, Kaushik RM, Gupta R, Kaushik R. Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India. Inflamm Intest Dis. 2020 Feb; 5(1): 1-10. doi 10.1159/000503921. Epub 2019 Nov 8.
Puentes JCP, Rocha H, Nicolau S, Ferrão G. Effectiveness of the MELD/Na Score and the Child-Pugh Score for the Identification of Palliative Care Needs in Patients with Cirrhosis of the Liver. Indian J Palliat Care. 2018 Oct-Dec; 24(4): 526-8. doi 10.4103/IJPC.IJPC_97_18.
Mahmud N, Fricker Z, Hubbard RA, Ioannou GN, Lewis JD, Taddei TH et al. Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis. Hepatology. 2021 Jan; 73(1): 204-18. doi 10.1002/hep.31558. Epub 2020 Dec 10.
Wood NL, VanDerwerken D, Segev DL, Gentry SE. Correcting the sex disparity in MELD-Na. Am J Transplant. 2021 Oct; 21(10): 3296-304. doi: 10.1111/ajt.16731. Epub 2021 Jul 12.
Durand F, Antoine C, Soubrane O. Liver Transplantation in France. Liver Transpl. 2019 May; 25(5): 763-70. doi 10.1002/lt.25419. Epub 2019 Apr 1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
